FDA still is­n't re­al­ly throw­ing its weight be­hind Covid-19 vac­cine boost­ers, Mod­er­na's ad­comm brief­ing docs show

As the two top vac­cine ex­perts at the FDA re­tired in protest over the way the Covid-19 boost­er shot process has tran­spired, the agency on Tues­day re­leased its find­ings on the Mod­er­na vac­cine boost­er da­ta ahead of an ad­comm meet­ing lat­er this week, of­fer­ing the same ten­ta­tive sup­port that the Pfiz­er boost­er re­ceived.

While au­tho­riza­tion of the Mod­er­na boost­er is ba­si­cal­ly a done deal, as it was with Pfiz­er’s be­fore the process be­gan (since the post-au­tho­riza­tion CDC ad­vi­so­ry com­mit­tee has al­ready been sched­uled), the FDA’s brief­ing doc­u­ments make clear that the agency doesn’t find the da­ta on boost­er ef­fi­ca­cy to be par­tic­u­lar­ly per­sua­sive.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER